from Reuters: Top News https://ift.tt/2ICTgHV Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.
Roche bets $4.3 billion on Spark in gene therapy move
Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.
from Reuters: Top News https://ift.tt/2ICTgHV Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.
from Reuters: Top News https://ift.tt/2ICTgHV Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.
Related Posts:
China rebuffs Germany's call for U.S. missile deal with Russia- More U.S. aid for Venezuela touches down amid distribution uncertainty
- French police fire tear gas as latest 'yellow vest' protests turn violent
- Pence chastises EU, rejects Merkel's call to work with Russia
- Canada's Freeland pushes end of steel, aluminum tariffs in meeting with Pelosi
0 comments:
Post a Comment